electroCore Named One of The Americas’ Fastest Growing Companies by the Financial Times

Core Insights - electroCore, Inc. has been recognized by the Financial Times as one of "The Americas' Fastest Growing Companies 2025," debuting at number 125 among 300 companies [1][2] - The Financial Times' annual list ranks companies based on the highest compound annual revenue growth from 2020 to 2023, with the healthcare & life sciences sector representing 10% of the fastest-growing companies [2] - electroCore ranked 16th among 29 healthcare & life sciences companies included in the list, alongside notable firms such as BeiGene, Hims & Hers Health, and Progyny [2] Company Overview - electroCore is a commercial-stage bioelectronic medicine and wellness company focused on improving health through its non-invasive vagus nerve stimulation (nVNS) technology platform [4] - The company aims to commercialize medical devices for managing and treating specific medical conditions, as well as consumer products that utilize nVNS to enhance general well-being and human performance in the U.S. and select international markets [4] - The CFO of electroCore emphasized the company's commitment to delivering drug-free solutions for pain management, stress reduction, and sleep improvement, which contributed to its recognition by the Financial Times [3]